2002
DOI: 10.1590/s0041-87812002000100001
|View full text |Cite
|
Sign up to set email alerts
|

Prenatal tracheal ligation or intra-amniotic administration of surfactant or dexamethasone prevents some structural changes in the pulmonary arteries of surgically created diaphragmatic hernia in rabbits

Abstract: PURPOSE:Characterization of the structural changes occurring in the pulmonary arteries resulting from surgically produced congenital diaphragmatic hernia in rabbits, with particular emphasis on the preventive effects of prenatal tracheal ligation or administration of intra-amniotic dexamethasone or surfactant.METHODS: Twenty rabbit fetuses underwent surgical creation of a left-sided congenital diaphragmatic hernia on the 24th or 25th gestational day. They were divided according to the following procedures: con… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
8
0
2

Year Published

2007
2007
2018
2018

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 9 publications
(11 citation statements)
references
References 33 publications
(25 reference statements)
1
8
0
2
Order By: Relevance
“…These strategies consist of prenatal intra-amniotic administration of porcine surfactant or dexamethasone and prenatal tracheal ligation (TL), an invasive method that effectively treats or prevents pulmonary hypoplasia of CDH 1,2 . Based on functional, morphological, histomorphometric and biochemical studies, we proved that in this model, CDH is associated with hypoplastic lungs 3 , and the preventive effects of intra-amniotic administration of drugs on lung maturation were comparable to the changes induced by TL [4][5][6] . In addition to lung hypoplasia, pulmonary hypertension, biochemical and structural immaturity of CDH lungs, the hemodynamics of infants and animals with CDH are markedly altered 7,8 .…”
mentioning
confidence: 57%
See 1 more Smart Citation
“…These strategies consist of prenatal intra-amniotic administration of porcine surfactant or dexamethasone and prenatal tracheal ligation (TL), an invasive method that effectively treats or prevents pulmonary hypoplasia of CDH 1,2 . Based on functional, morphological, histomorphometric and biochemical studies, we proved that in this model, CDH is associated with hypoplastic lungs 3 , and the preventive effects of intra-amniotic administration of drugs on lung maturation were comparable to the changes induced by TL [4][5][6] . In addition to lung hypoplasia, pulmonary hypertension, biochemical and structural immaturity of CDH lungs, the hemodynamics of infants and animals with CDH are markedly altered 7,8 .…”
mentioning
confidence: 57%
“…Despite all refinements of the current management, survival rates of patients with CDH remains frustratingly low because of pulmonary hypoplasia, biochemical immaturity of lungs, and arterial thickening and constriction with persistence of the fetal circulation pattern 6 . In addition, associated anomalies-primarily cardiac anomaliesaccount for many of the deaths.…”
Section: Discussionmentioning
confidence: 99%
“…O efeito maturador da TO parece residir, sobretudo, na ação mecânica que exerce no parênquima pulmonar, consoante ao demonstrado que a aceleração do crescimento celular está diretamente relacionada ao aumento da pressão intratraqueal 13,14,15 . Esse estímulo físico, além de recuperar o espaço pulmonar perdido pela herniação na HDC e restabelecer a arquitetura pulmonar, estimula processos moleculares, culminando com maior transcrição gênica, maior produção protéica e conseqüentemente desenvolvimento e diferenciação celular confluindo para acelerar a maturação pulmonar 7,16 . O VEGF pode ser localizado nos pulmões, rins e ossos, sendo secretado por células endoteliais e outras como espermatozóides e pneumócitos, sendo considerado um mediador parácrino e autócrino.…”
Section: Discussionunclassified
“…A TO pode atuar reduzindo alterações na produção de VEGF ou de seus receptores, na medida em que reverte mecanicamente o desarranjo da arquitetura pulmonar 6 bem como, pode aumentar a diferenciação dos pneumócitos II em tipo I e melhorar a hipoplasia pulmonar, especialmente quando associado ao aumento da produção de surfactante estimulada pelo corticóide 7,8 . A participação do VEGF no desenvolvimento pulmonar e na produção de surfactante tem sido correlacionada, o VEGF parece induzir a conversão de glicogênio em surfactante nos pneumócitos II 6 , no entanto, poucos estudos abordam os receptores de VEGF.…”
Section: Introductionunclassified
“…We, as well as others, already looked at the vascular effects of prenatal steroids in preterm rabbits, showing a dose-dependent reduction in arterial medial thickness and number of small muscularized (ED≤ 60 µm) peripheral pulmonary vessels (Roubliova et al, 2007). In lungs of rabbits with DH, GC reverse structural changes, such as medial thickening of pulmonary vessels (Tannuri et al, 1998a,b;Rodrigues et al, 2002). Herein, we aimed to investigate the pulmonary effects of GC in rabbits with CDH, which also underwent TO and were delivered at term.…”
Section: Introductionmentioning
confidence: 94%